FDA Panel Supports First Biologic Drug Copy

January 9, 2015 5:22 PM

1 0

A new recommendation moves “biosimilars” one step closer to bringing down the costs of cancer treatment

Generic competition for Neupogen, a cancer drug that helps ward off infections while patients are undergoing chemotherapy, is one step closer to being available in the United States.

Read more

To category page